- Home
- TNGX vs PDFS Comparison
TNGX vs PDFS Comparison
Compare TNGX & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- PDFS
- Stock Information
- Founded
- TNGX 2014
- PDFS 1992
- Country
- TNGX United States
- PDFS United States
- Employees
- TNGX N/A
- PDFS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- PDFS EDP Services
- Sector
- TNGX Health Care
- PDFS Technology
- Exchange
- TNGX Nasdaq
- PDFS Nasdaq
- Market Cap
- TNGX 723.2M
- PDFS 764.2M
- IPO Year
- TNGX N/A
- PDFS N/A
- Fundamental
- Price
- TNGX $6.90
- PDFS $20.28
- Analyst Decision
- TNGX Strong Buy
- PDFS Strong Buy
- Analyst Count
- TNGX 6
- PDFS 3
- Target Price
- TNGX $10.00
- PDFS $33.33
- AVG Volume (30 Days)
- TNGX 1.9M
- PDFS 324.1K
- Earning Date
- TNGX 08-05-2025
- PDFS 08-07-2025
- Dividend Yield
- TNGX N/A
- PDFS N/A
- EPS Growth
- TNGX N/A
- PDFS N/A
- EPS
- TNGX N/A
- PDFS 0.02
- Revenue
- TNGX $24,296,000.00
- PDFS $196,000,000.00
- Revenue This Year
- TNGX N/A
- PDFS $23.39
- Revenue Next Year
- TNGX N/A
- PDFS $18.37
- P/E Ratio
- TNGX N/A
- PDFS $932.38
- Revenue Growth
- TNGX N/A
- PDFS 17.76
- 52 Week Low
- TNGX $1.03
- PDFS $15.91
- 52 Week High
- TNGX $12.02
- PDFS $33.42
- Technical
- Relative Strength Index (RSI)
- TNGX 56.63
- PDFS 45.32
- Support Level
- TNGX $6.60
- PDFS $19.00
- Resistance Level
- TNGX $7.42
- PDFS $19.91
- Average True Range (ATR)
- TNGX 0.47
- PDFS 1.06
- MACD
- TNGX -0.04
- PDFS -0.14
- Stochastic Oscillator
- TNGX 57.20
- PDFS 44.08
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About PDFS PDF Solutions Inc.
PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.